G-CSF use in patients receiving first-line chemotherapy for non-Hodgkin’s lymphoma (NHL) and granulocyte-colony stimulating factors (G-CSF) as observed in clinical practice in Italy
Crossref DOI link: https://doi.org/10.1007/s12032-016-0850-9
Published Online: 2016-11-07
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vitolo, Umberto
Angrili, Francesco
DeCosta, Lucy
Wetten, Sally
Federico, Massimo
Funding for this research was provided by:
Amgen Limited
License valid from 2016-11-07